Community
Advertising Opportunities
Biotechnology Europe Programs
Biotechnology Europe Community
Feedback
Contact
Biotechnology Europe Advantages
Advertising Opportunities on Biotechnology Europe
Sponsorship Opportunities on Biotechnology Europe
Post a Job on Biotechnology Europe
Post a Company Profile on Biotechnology Europe
Post a News on Biotechnology Europe
Post an Event on Biotechnology Europe
Post a Product on Biotechnology Europe
Post a Publication on Biotechnology Europe
Post a Technology on Biotechnology Europe
Post a Resume on Biotechnology Europe
Terms of Business
Imprint
Privacy Policy
FAQ
Subscribe Newsletter
CLINICAL TRIALS NEWS
18.09.2007 MorphoSys AG Announces Clinical Milestone in Antibody Program - Fourth HuCAL-based Antibody to Begin Clinical Trials
05.09.2007 Merck: Stimuvax® Therapeutic Cancer Vaccine – Phase II Data Highlight Three-Year Survival Results for Lung Cancer Patients
16.07.2007 ACADIA Pharmaceuticals Earns Milestone on Advancement of Glaucoma Drug Candidate
11.07.2007 Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
07.07.2007 Cancer-Fighting Virus Shows Promise in Early Clinical Trial
29.06.2007 Merck’s Fertility Treatment Pergoveris Approved in European Union
28.06.2007 European Union CHMP Recommends Approval of New Formulation of Multiple Sclerosis Treatment Rebif® (interferon beta-1a)
26.06.2007 ACADIA Pharmaceuticals Initiates Phase IIb Clinical Trial with ACP-104 in Patients with Schizophrenia
26.06.2007 Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
